CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Purchase | +868,066 | $10.00 | $8.7M | 1,240,575 |
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Option exercise | +174 | $0.20 | $35 | 174 |
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Option exercise | +174 | $0.20 | $35 | 348 |
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Option exercise | +3,033 | $0.20 | $607 | 3,381 |
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Conversion | +5,931 | 9,312 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Conversion | +1,848 | 11,160 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Conversion | +2,642 | 13,802 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Purchase | +31,934 | $10.00 | $319K | 45,736 |
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Option exercise · Common Stock Warrant (right to buy) | −4,551 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Option exercise · Common Stock Warrant (right to buy) | −4,551 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Option exercise · Common Stock Warrant (right to buy) | −82,454 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Conversion · Series C Preferred Stock | −570,159 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Conversion · Series D-1 Preferred Stock | −1,024,876 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Conversion · Series D-2 Preferred Stock | −1,417,315 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Option exercise · Common Stock Warrant (right to buy) | −174 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Option exercise · Common Stock Warrant (right to buy) | −174 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Option exercise · Common Stock Warrant (right to buy) | −3,033 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Conversion · Series C Preferred Stock | −20,975 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Conversion · Series D-1 Preferred Stock | −37,702 | 0 | ||
| 2014-05-07 | ALTA BIOPHARMA PARTNERS II LP 10% owner | Conversion · Series D-2 Preferred Stock | −53,915 | 0 |
Page 24 of 26 · 507 trades